Loading company
Just reported
Q1 FY2027 results
From Accuray's results release of November 4, 2026; its quarterly report has since been filed.
Revenue
Actual
$86.5M
-7.9% y/y
-14% q/qGuided
—
No guide given
EPS, GAAP
Actual
$0.07
Guided
—
No guide given
Operating income, GAAP
Actual
-$36.5M
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes Accuray is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Devices
Graded A or B and worth $2B or more: A first, then the largest.
MDTMedtronic plc$131.6BA+
SYKStryker Corp.$117.9BA+
EWEdwards Lifesciences Corporation$61.6BA+
GEHCGE Healthcare Technologies Inc.$37.5BA
GKOSGlaukos Corp$14.5BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher CorporationOct 21, 2026CBGraded C, now B
MCKMckesson CorporationNov 4, 2026BAGraded B, now A
CVSCVS Health CorpNov 4, 2026BAGraded B, now A- EWEdwards Lifesciences CorporationNov 4, 2026BAGraded B, now A
- GEHCGE Healthcare Technologies Inc.Oct 28, 2026CAGraded C, now A
Built from Accuray Incorporated’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
